Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal fentanyl and S-ketamine for acute pain in minor trauma patients
2017-002167-18Phase 4Terminated
- Sponsor
- Anna Meuronen
- Start
- Jul 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute pain comparing Intranasal fentanyl, Intranasal esketamine and Placebo (3 arms). Primary endpoints: Change in NRS pain score in the first part of the study, Need for oxycodone in the first part of the study and 1 more. Started Jul 2017; status: terminated.
02
Drugs
fentanylesketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on 2017-002167-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002167-18.